Abstract:Background: Comorbidities such as obesity and type 2 diabetes mellitus (T2DM) have emerged as critical risk factors exacerbating the severity and mortality of COVID-19. Meanwhile, numerous genome-wide association studies (GWAS) have identified single nucleotide polymorphisms (SNPs) associated with increased susceptibility to severe COVID-19. Aim: This study investigated whether SNPs previously identified by GWAS as risk factors for severe COVID-19 also correlate with common comorbidities-obesity and T2DM-in hospitalized patients with severe COVID-19. Methods: DNA samples from 199 hospitalized COVID-19 patients were genotyped using probe-based PCR for 10 GWAS SNPs previously implicated in severe COVID-19 outcomes (rs143334143 CCHCR1, rs111837807 CCHCR1, rs17078346 SLC6A20-LZTFL1, rs17713054 SLC6A20-LZTFL1, rs7949972 ELF5, rs61882275 ELF5, rs12585036 ATP11A, rs67579710 THBS3, THBS3-AS1, rs12610495 DPP9, rs9636867 IFNAR2). Results: The analysis revealed significant associations between certain SNPs and the increased risk of obesity and T2DM in severe COVID-19 patients. Specifically, rs17713054 SLC6A20-LZTFL1 (risk allele A; odds ratio (OR) = 2.34, 95% confidence interval (CI) = 1.24-4.4, p = 0.007) and rs7949972 ELF5 SNP (risk allele T; OR = 1.79, 95% CI = 1.11-2.91, p = 0.015) were associated with increased risk of obesity. SNP rs9636867 IFNAR2 was associated with a higher risk of T2DM (risk allele G, OR = 8.28, 95% CI = 1.69-40.64, p = 0.027). Using the model-based multifactor dimensionality reduction (MB-MDR) approach, the six most significant gene-gene interaction patterns associated with obesity in severe COVID-19 patients were identified and included five polymorphic loci: rs7949972, rs17713054, rs61882275, rs12585036, and rs143334143, participating in two or more of the most significant G-G interactions (pperm < 0.05). In total, the best models of G-G interactions associated with T2DM in patients with severe COVID-19 included eight polymorphic loci, six of which, rs7949972, rs61882275, rs12585036, rs143334143, rs67579710, and rs12610495, were involved in two or more of the most significant G-G interactions. Conclusions: Our study provides novel insights into the genetic associations between GWAS-identified SNPs and the risk of obesity and T2DM in patients with severe COVID-19.

Genome-wide screening of sex-biased genetic variants potentially associated with COVID-19 hospitalization

Targeted screening of genetic associations with COVID-19 susceptibility and severity

A systematical association analysis of 25 common virus infection and genetic susceptibility of COVID-19 infection

Trans-ethnic genome-wide association study of severe COVID-19

Host Genetic Factors, Comorbidities and the Risk of Severe COVID-19

Genome-wide association study of COVID-19 severity among the Chinese population

Genetic screening for hypertension and COVID-19 reveals functional variation of SPEG potentially associated with severe COVID-19 in women

Sex Differences in Severity and Mortality Among Patients With COVID-19: Evidence from Pooled Literature Analysis and Insights from Integrated Bioinformatic Analysis

Genetic Variants Are Identified to Increase Risk of COVID-19 Related Mortality from UK Biobank Data.

Sex-Disaggregated Data on Clinical Characteristics and Outcomes of Hospitalized Patients With COVID-19: A Retrospective Study

Establishment of sex-specific predictive models for critical illness in Chinese people with the Omicron variant

Sex Differences in Viral Entry Protein Expression and Host Transcript Responses to SARS-CoV-2

Sex-based clinical and immunological differences in COVID-19

Sex Differences in Patients with COVID-19: a Retrospective Cohort Study and Meta-Analysis

Sex differences in immune responses that underlie COVID-19 disease outcomes

Sex-specific Causal Effects of Serum Sex Hormones on COVID-19 Susceptibility and Severity: Evidence from the UK Biobank and COVID-19 Host Genetics Initiative

GWAS-Identified Loci are Associated with Obesity and Type 2 Diabetes Mellitus in Patients with Severe COVID-19

Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility

Potential Similarities in Sex Difference in Key Genes and Their Expression, Network, EQTL and Pathways between COVID-19 and Chronic Kidney Disease Based on Mouse Model

Genetically predicted high IGF-1 levels showed protective effects on COVID-19 susceptibility and hospitalization: a Mendelian randomisation study with data from 60 studies across 25 countries

Human Genetic Variants Associated with COVID-19 Severity Are Enriched in Immune and Epithelium Regulatory Networks